To provide the right treatment for MS, it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently recognised on average three years too late. Researchers at Uppsala University have now developed an AI model that can determine with 90 percent certainty which variant the patient has.
Multiple sclerosis (MS) is a chronic, inflammatory disease of the central nervous system. In Sweden, there are approximately 22,000 people…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply